ChristianaCare Spins Out CorriXR Therapeutics

On October 11, 2022, Wilmington, Delaware-based ChristianaCare announced it had spun out its first commercial biotechnology private startup company, CorriXR Therapeutics. The startup will use CRISPR gene editing technology to develop new, clinically relevant oncologic therapeutics in areas of unmet medical need, starting with squamous cell carcinoma of the lung.

CorriXR Therapeutics’ close relationship with ChristianaCare and the ChristianaCare Gene Editing Institute uniquely positions the new company to research and develop innovative, patient-centered therapies, the nonprofit health system said in its release. CorriXR Therapeutics will license technology from the Gene Editing Institute and work closely with its […]

Life Sciences PA Shares Industry Impact Report

Our region’s life sciences ecosystem has three new assets we can all use to amplify the discovery, talent, and momentum in Greater Philadelphia. The first is a study by Econsult ranking Greater Philadelphia #2 in cell and gene therapy compared with 14 U.S. cell and gene therapy clusters. You can read about the research and link to the report here; it was recently featured in the trade publication Cell & Gene. The second is JLL’s  2022 Life Sciences Research Outlook & Cluster Rankings, in […]

Comparative Study Ranks Philadelphia Region #2 Among 14 Cell and Gene Therapy Hubs

In a newly released study comparing 14 U.S. cell and gene therapy hubs in five key categories, the Philadelphia region ranks #2 among U.S. locations. Commissioned by the Chamber of Commerce for Greater Philadelphia and researched by economic consulting firm Econsult Solutions, Inc. (ESI), the study compares cell and gene therapy hubs in research infrastructure, human capital, innovation output, commercial activity, and value proposition. The only region ranked higher overall than Philadelphia was Boston. New York and San Francisco were ranked #3 and #4, respectively.

“The Philadelphia region is increasingly attracting new […]

Five Organizations Partner to Design New Biotech Training Program to Connect Philadelphians with Quality Jobs in the Region’s Rapidly Growing Life Sciences Sector

The Wistar Institute, West Philadelphia Skills Initiative, Iovance Biotherapeutics, PIDC, and The Chamber of Commerce for Greater Philadelphia Launch Recruitment for the Pilot Program.

Partners in Greater Philadelphia’s life sciences ecosystem are collaborating to create a new workforce development training model to connect biotech jobs with a wider range of Philadelphians, including residents from disadvantaged communities. In a field that often requires PhDs or master’s degrees for most roles, the program – “Biomedical Technician Training Program: Aseptic Manufacturing” – will create opportunities for Philadelphians with at least a high school equivalency. The initiative is one way the region is working together […]

Philadelphia Region’s Ever-Expanding Cell and Gene Therapy Family Tree Featured in New Promotional Reel

An initiative launched more than three years ago to boost awareness of the region as a hub for cell and gene therapy is getting ready to unveil its latest effort to promote the fast-growing sector.

Called “Greater Philadelphia: Discovery Starts Here,” the 90-second graphic animation illustrates how more than a dozen companies have spun out of, or are licensing technology from, a handful of local research institutions. It is also available for download here.

Specifically, the video animation features five research institutions (The University of Pennsylvania, Children’s Hospital of Philadelphia, Jefferson Health, Temple University, and The Wistar […]

AmerisourceBergen Establishes Cell and Gene Therapy Service Line

AmerisourceBergen, a global healthcare services company headquartered in Greater Philadelphia, announced it has formally established a cell and gene therapy service line as part of its commitment to support cell and gene therapy innovators. This new service line will be led by Lung-I Cheng, Ph.D., who recently joined AmerisourceBergen as Vice President of Cell and Gene Therapy. 

Cheng will work to evolve and enhance the end-to-end support AmerisourceBergen provides cell and gene therapy innovators throughout the commercialization journey. As part of that effort, Cheng noted AmerisourceBergen […]

Discovery, Accessibility and Affordability: Three Reasons to Join the Thousands of Cell & Gene Therapy Employees Already Working in Greater Philadelphia

For the nearly 5,000 employees working cell & gene therapy who call Philadelphia home, it has proven to be the best of both worlds with attributes that satisfy both your personal and professional life.

Philadelphia’s Talent Pipeline Collaborative Readies Region For Cell And Gene Therapy Job Growth

Claire Greenwood, Executive Director, CEO Council for Growth, and Patricia Day, Manager, Leadership Engagement, the Chamber of Commerce for Greater Philadelphia elaborate on the creation of the Life Science Talent Pipeline Collaborative in an op-ed originally published at CellandGene.com.

Region’s Reputation for Cell & Gene Therapy Grew in 2020

The Greater Philadelphia region’s reputation as a center for the cell and gene therapy industry grew in 2020 as breakthrough research from industry academia pioneers is increasingly complemented by strong capital investment and real estate projects meeting the specialized land, building, and lab development needs of start-up, scaling and relocating companies.

Investment

According to research from biopharma database company DealForma (as of December 9, 2020), the Greater Philadelphia region saw 49 life sciences investment deals in 2020, valued at more than $12 billion, including six in the cell and gene therapy space totaling $4.5 billion. Among the cell and gene therapy investment […]

Go to Top